These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1604654

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Heterotopic pancreas transplantation does not necessarily confer basal hyperinsulinemia.
    Cantarovich D, Guillemet B, Cagliotti A, Murat A, Krempf M, Soulillou JP.
    Transplant Proc; 1994 Apr; 26(2):475. PubMed ID: 8171512
    [No Abstract] [Full Text] [Related]

  • 3. Basal and stimulated endocrine metabolic function in recipients of pancreatico-duodenal grafts.
    Czerwiński J, Fiedor P, Michalak G, Durlik M, Paczek L, Adadyński L, Lagiewska B, Pacholczyk M, Szostek M, Lao M, Wałaszewski J, Rowiński W.
    Transplant Proc; 1996 Dec; 28(6):3509-10. PubMed ID: 8962363
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic results at 6 and 12 months after pancreas transplantation.
    Sousa-Castello A, Lefrancois N, Martin X, Caldara R, Pouteil-Noble C, Touraine JL, Dubernard JM.
    Transplant Proc; 1992 Jun; 24(3):839. PubMed ID: 1604632
    [No Abstract] [Full Text] [Related]

  • 5. Glucose tolerance following segmental and whole-organ pancreas transplantation.
    Saudek F, Jedináková T, Adamec M, Vlasáková Z, Bartos V.
    Transplant Proc; 1997 Nov; 29(7):3121. PubMed ID: 9365691
    [No Abstract] [Full Text] [Related]

  • 6. Long-term metabolic control in recipients of combined pancreas and kidney transplants.
    Holdaas H, Brekke IB, Hartmann A, Bentdal OH, Ganes T, Gjellestad A, Fauchald P, Berg KJ, Djøseland O, Jervell J.
    Diabetologia; 1991 Aug; 34 Suppl 1():S68-70. PubMed ID: 1936699
    [Abstract] [Full Text] [Related]

  • 7. Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation (DSSGMEPT).
    Christiansen E, Tibell A, Rasmussen K, Tydén G, Madsbad S.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1186-9. PubMed ID: 8442082
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Absence of severe hyperinsulinemia after pancreas/kidney transplantation with peripheral venous drainage.
    Pfeffer F, Nauck MA, Erb M, Benz S, Hopt UT.
    Transplant Proc; 1997 Feb; 29(1-2):645-6. PubMed ID: 9123459
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up.
    Holdaas H, Brekke IB, Hartmann A, Fauchald P, Berg KJ, Sødal G, Jervell J, Flatmark A.
    Transplant Proc; 1990 Apr; 22(2):655-6. PubMed ID: 2327010
    [No Abstract] [Full Text] [Related]

  • 12. Whole versus segmental pancreas graft: two years metabolic results.
    La Rocca E, Martin X, Secchi A, Lefrançois N, Martinenghi S, Melandri M, Touraine JL, Pozza G, Dubernard JM.
    Transplant Proc; 1990 Apr; 22(2):653-4. PubMed ID: 2183436
    [No Abstract] [Full Text] [Related]

  • 13. Acute deterioration of pancreatic graft function presumably determined by steroid-induced insulin resistance: a case report.
    Martinenghi S, Secchi A, Luzi L, Battezzati A, DiCarlo V, Pozza G.
    Transplantation; 1993 Jul; 56(1):241-4. PubMed ID: 8333058
    [No Abstract] [Full Text] [Related]

  • 14. Pancreas transplantation in the uremic patient: a random trial of total pancreas with bladder drainage versus duct obstruction of segmental grafts.
    Martin X, Lefrancois N, Dawhara M, Bret M, Brunet M, Desmettre O, Garnier JL, Pouteil-Noble C, Dubernard JM.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1182-3. PubMed ID: 8442080
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of type II diabetes after combined kidney-pancreas transplantation in a patient with type I (insulin-dependent) diabetes.
    Wadström J, Gannedahl G, Wahlberg J, Frödin L, Tedbrandt A, Berne C.
    Transplant Proc; 1994 Jun; 26(3):1761-2. PubMed ID: 7518156
    [No Abstract] [Full Text] [Related]

  • 17. A 10-year prospective study of IDDM patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone.
    Tydén G, Bolinder J, Solders G, Nakache R, Brattström C, Tibell A, Groth CG.
    Transplant Proc; 1997 Nov; 29(7):3119. PubMed ID: 9365689
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endocrinometabolic effects of whole versus segmental pancreas allotransplantation in diabetic patients--a two-year follow-up.
    Secchi A, Dubernard JM, La Rocca E, LeFrancois N, Melandri M, Martin X, Touraine JL, Traeger J, Pozza G.
    Transplantation; 1991 Mar; 51(3):625-9. PubMed ID: 2006518
    [Abstract] [Full Text] [Related]

  • 20. Continuous subcutaneous insulin infusion in a patient with partial endocrine pancreatic graft function.
    Giannarelli R, Aragona M, Coppelli A, Boggi U, Rizzo G, Marsocci A, Mosca F, Del Prato S, Marchetti P.
    Transplant Proc; 2001 Mar; 33(7-8):3500-1. PubMed ID: 11750496
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.